Chemoinformaics analysis of 9,14-DIHYDROXYOCTADECANOIC ACID
| Molecular Weight | 316.482 | nRot | 16 |
| Heavy Atom Molecular Weight | 280.194 | nRig | 1 |
| Exact Molecular Weight | 316.261 | nRing | 0 |
| Solubility: LogS | -3.747 | nHRing | 0 |
| Solubility: LogP | 3.986 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 58 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 57.2725 |
| nHD | 3 | BPOL | 36.9835 |
| QED | 0.371 |
| Synth | 2.897 |
| Natural Product Likeliness | 0.724 |
| NR-PPAR-gamma | 0.987 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.228 |
| Pgp-sub | 0.153 |
| HIA | 0.115 |
| CACO-2 | -5.26 |
| MDCK | 0.000052 |
| BBB | 0.251 |
| PPB | 0.937993 |
| VDSS | 0.504 |
| FU | 0.0344844 |
| CYP1A2-inh | 0.051 |
| CYP1A2-sub | 0.354 |
| CYP2c19-inh | 0.02 |
| CYP2c19-sub | 0.159 |
| CYP2c9-inh | 0.071 |
| CYP2c9-sub | 0.975 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.071 |
| CYP3a4-inh | 0.009 |
| CYP3a4-sub | 0.015 |
| CL | 10.068 |
| T12 | 0.795 |
| hERG | 0.031 |
| Ames | 0.005 |
| ROA | 0.001 |
| SkinSen | 0.862 |
| Carcinogencity | 0.05 |
| EI | 0.855 |
| Respiratory | 0.102 |
| NR-Aromatase | 0.189 |
| Antiviral | Yes |
| Prediction | 0.582333 |